We are live on
!
Find out more
CTC
Central Trust Company Portfolio holdings
AUM
$5.08B
1-Year Est. Return
25.65%
This Fund
S&P 500
This Quarter
Est. Return
-4.73%
1 Year Est. Return
+25.65%
3 Year Est. Return
+74.65%
5 Year Est. Return
+97.11%
10 Year Est. Return
+319.6%
AUM
$2.92B
AUM Growth
-$116M
(-3.8%)
Cap. Flow
+$48.3M
Cap. Flow
% of AUM
1.66%
Top 10 Holdings %
Top 10 Hldgs %
29.56%
Holding
1,454
New
60
Increased
360
Reduced
379
Closed
150
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares 0-5 Year TIPS Bond ETF
STIP
|
+$15.5M |
| 2 |
Vanguard High Dividend Yield ETF
VYM
|
+$8.88M |
| 3 |
Schwab US Dividend Equity ETF
SCHD
|
+$5.68M |
| 4 |
Vanguard Intermediate-Term Bond ETF
BIV
|
+$4.84M |
| 5 |
Sprott Physical Gold
PHYS
|
+$3.8M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
JPMorgan Ultra-Short Income ETF
JPST
|
+$5.37M |
| 2 |
Sprott Physical Silver Trust
PSLV
|
+$3.33M |
| 3 |
iShares 1-5 Year Investment Grade Corporate Bond ETF
IGSB
|
+$3.32M |
| 4 |
Nuveen ESG Mid-Cap Growth ETF
NUMG
|
+$2.62M |
| 5 |
IBDN
iShares iBonds Dec 2022 Term Corporate ETF
IBDN
|
+$1.98M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 14.57% |
| 2 | Healthcare | 9.32% |
| 3 | Consumer Staples | 6.58% |
| 4 | Consumer Discretionary | 6.3% |
| 5 | Industrials | 5.97% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
26
Johnson & Johnson
JNJ
$617B
| $27.5M | 0.94% |
168,111
+1,550
| +0.9% | +$262K |
|
27
McDonald's
MCD
$191B
| $27.2M | 0.93% |
117,912
+312
| +0.3% | +$79.7K |
|
28
Chevron
CVX
$383B
| $26.5M | 0.91% |
184,635
-3,762
| -2% | -$574K |
|
29
Walmart Inc
WMT
$884B
| $25.7M | 0.88% |
595,362
-12,414
| -2% | -$544K |
|
30
ExxonMobil
XOM
$651B
| $24.8M | 0.85% |
283,952
-3,816
| -1% | -$348K |
|
31
Pfizer
PFE
$142B
| $24.6M | 0.84% |
562,972
-4,508
| -0.8% | -$219K |
|
32
Honeywell
HON
$76.7B
| $23.1M | 0.79% |
146,701
-1,514
| -1% | -$264K |
|
|
33
Sprott Physical Silver Trust
PSLV
$12.2B
| $21.3M | 0.73% |
3,215,697
-502,840
| -14% | -$3.33M |
|
34
Vanguard FTSE Developed Markets ETF
VEA
$230B
| $18.8M | 0.65% |
518,196
+28,613
| +6% | +$1.17M |
|
35
JPMorgan Chase
JPM
$933B
| $18.6M | 0.64% |
178,408
-3,544
| -2% | -$407K |
|
36
JPMorgan Equity Premium Income ETF
JEPI
$45.7B
| $18.3M | 0.63% |
358,172
+56,063
| +19% | +$3.12M |
|
37
SPDR Gold Trust
GLD
$133B
| $17.5M | 0.6% |
113,258
-1,789
| -2% | -$288K |
|
|
38
JPMorgan Ultra-Short Income ETF
JPST
$40.1B
| $17.4M | 0.6% |
346,142
-107,115
| -24% | -$5.37M |
|
|
IBDN
39
DELISTED
iShares iBonds Dec 2022 Term Corporate ETF
IBDN
| $17.2M | 0.59% |
688,138
-79,243
| -10% | -$1.98M |
|
40
NextEra Energy
NEE
$183B
| $17M | 0.58% |
217,067
+2,023
| +0.9% | +$172K |
|
41
Abbott
ABT
$183B
| $16.8M | 0.58% |
173,677
+9,991
| +6% | +$1.06M |
|
42
Bristol-Myers Squibb
BMY
$132B
| $16.6M | 0.57% |
233,297
-1,186
| -0.5% | -$86K |
|
|
IBDO
43
DELISTED
iShares iBonds Dec 2023 Term Corporate ETF
IBDO
| $15.8M | 0.54% |
634,197
+86,269
| +16% | +$2.16M |
|
44
Thermo Fisher Scientific
TMO
$214B
| $14.6M | 0.5% |
28,771
-235
| -0.8% | -$132K |
|
45
Visa
V
$673B
| $14.6M | 0.5% |
81,950
-1,255
| -2% | -$255K |
|
|
IBDP
46
DELISTED
iShares iBonds Dec 2024 Term Corporate ETF
IBDP
| $14.1M | 0.48% |
577,353
+96,449
| +20% | +$2.38M |
|
47
Eli Lilly
LLY
$1.03T
| $13.8M | 0.47% |
42,800
+1,582
| +4% | +$501K |
|
48
RTX Corp
RTX
$289B
| $13.7M | 0.47% |
167,436
-3,856
| -2% | -$349K |
|
49
Mastercard
MA
$510B
| $13.5M | 0.46% |
47,358
-812
| -2% | -$269K |
|
|
50
Vanguard High Dividend Yield ETF
VYM
$80.9B
| $12.8M | 0.44% |
135,160
+85,433
| +172% | +$8.88M |
|
Similar funds
JIM
LFG
VT
NC
CS
EIC
AC
CIA
Central Trust Company's Q3 2022 Portfolio in Review
As of Q3 2022, Central Trust Company held 1,454 positions worth $2.92B, down 3.8% from $3.03B the previous quarter. Its ten largest holdings account for 30% of the portfolio.
Central Trust Company's Q3 2022 filing shows 60 new, 360 increased, 379 reduced and 150 closed positions. Its largest new stake was ProShares Short S&P500: 24,887 shares worth $1.72M. The largest sale was JPMorgan Ultra-Short Income ETF, an estimated $5.37M.
By sector, the portfolio is most concentrated in Technology at 15% of assets, down from 15% a quarter earlier, followed by Healthcare and Consumer Staples.
- Central Trust Company's largest Q3 2022 buy was ProShares Short S&P500: 24,887 shares worth $1.72M.
- Central Trust Company added most to iShares 0-5 Year TIPS Bond ETF in Q3 2022, an estimated $15.5M increase.
- Central Trust Company's biggest Q3 2022 reduction was JPMorgan Ultra-Short Income ETF, cutting an estimated $5.37M.
- Central Trust Company fully exited Sprott Physical Platinum and Palladium Trust in Q3 2022, selling an estimated $847K.
- Central Trust Company's ten largest holdings make up 30% of its $2.92B portfolio in Q3 2022.
- Central Trust Company opened 60 new positions and closed 150 in Q3 2022.
- Central Trust Company's portfolio value fell 3.8% quarter-over-quarter to $2.92B.
Based on Central Trust Company's 13F filing for Q3 2022, filed 3 Nov 2022.